Delivery Order SPE2DB20D7059-SPE2DB25FQNR8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,321.10 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on August 12, 2025, carries a firm fixed price structure with an ultimate completion date of September 3, 2025. This is a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a $3,096.33 delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of September 11, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $66,055.04 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on August 7, 2025, with an ultimate completion date of August 28, 2025, carries firm fixed pricing and represents a competitive award with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this delivery order, which falls under the company's...
- The Defense Logistics Agency has awarded a delivery order valued at $30,963.30 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on August 5, 2025, carries a firm fixed price and has an ultimate completion date of August 26, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside contract awarded through competitive procurement, reflecting the contractor's...
- The Defense Logistics Agency awarded a $19,808.64 delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on August 13, 2025, with an ultimate completion date of September 4, 2025. This is a firm fixed-price, non-set-aside contract issued under a child delivery order structure. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order derives from AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,106.02 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on August 11, 2025, with an ultimate completion date of September 2, 2025, utilizes firm fixed pricing under a non-set-aside competitive procurement. Performance of this delivery order will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents valued at $4,128.44 under a firm fixed price contract type. The order was competitively awarded without a set-aside designation and is scheduled for completion by September 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,158.88 on August 14, 2025, for Varivax vaccine with diluents to be delivered to Conshohocken, Pennsylvania, with a completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,159.03 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of August 22, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, competitively awarded through open procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents valued at $1,042.56 under a firm fixed price arrangement. The award was made on August 20, 2025, with an ultimate completion date of September 11, 2025. This is a competitive, non-set-aside award with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQNR8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,106.02 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on August 20, 2025, with an ultimate completion date of September 11, 2025. The contract utilizes firm fixed pricing and is classified as a non-set-aside competitive award. AmerisourceBergen's corporate office, located in Conshohocken, Pennsylvania, serves as both the place of performance and the vendor's headquarters, positioning the company to efficiently fulfill this medical supply requirement for the federal government. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive prime contract vehicle enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally, including vaccines and other critical medical commodities for the Defense Health Agency and other government healthcare systems. The company's consistent receipt of competitively awarded delivery orders demonstrates its established capability to meet federal procurement requirements within the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/20/25 |